恩替卡韦
医学
替比夫定
HBeAg
内科学
胃肠病学
血清转化
肝硬化
安慰剂
乙型肝炎病毒
慢性肝炎
乙型肝炎
不利影响
荟萃分析
病毒学
病毒
乙型肝炎表面抗原
拉米夫定
病理
替代医学
作者
Jinsong Geng,Haini Bao,Yalan Chen,Lili Shi,Jing Geng,Qing Wang,Hao Yu
标识
DOI:10.1080/14787210.2020.1760843
摘要
The nucleos(t)ide analogues are all effective for HBeAg seroconversion, HBeAg loss, undetectable HBV DNA, and most are effective for ALT normalization in adults with CHB. RCTs of multi-center, low risk of bias, and long-term follow-up are still needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI